Amendment to the Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV)

The Commission, in consultation with the National Pathology Accreditation Advisory Council (NPAAC), advises of an amendment to the confirmatory testing for HIV and HCV of the Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV).

Print

The amendment is to support:

  • a consistent national approach to automatic reflexive HCV RNA testing
  • the goal of eliminating HCV as a public health threat by 2030
  • harmonisation of testing algorithms with international practice.

Specifically, the amendments include:

  • additions to Appendix A
  • an update to C10.1(ii), now renumbered as C6.01(b).

The amendment is enforceable from 23 March 2026. 

The updated version of the Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (Fifth Edition, 2026) is available on the Commission’s website.

View the Standard

More information

Visit safetyandquality.gov.au/pathology or email pathology@safetyandquality.gov.au

Subscribe here to receive news and updates on the Pathology Standards.

Topics
Pathology
Back to top